Prime and target immunization protects against liver-stage malaria in mice

Prime and target immunization protects against liver-stage malaria in mice

Despite recent advances in treatment and vector control, malaria is still a leading cause of death, emphasizing the need for an effective vaccine. The malaria life-cycle can be sub divided into three stages: the invasion and growth within liver hepatocytes (pre-erythrocytic stage), the blood- (eryth...

書目詳細資料
Main Authors:	Gola, A, Silman, D, Walters, A, Uderhardt, S, Salman, A, Halbroth, B, Bellamy, D, Bowyer, G, Powlson, J, Baker, M, Venkatraman, N, Poulton, I, Berrie, E, Roberts, R, Lawrie, A, Angus, B, Khan, S, Janse, C, Ewer, K, Germain, R, Spencer, A, Hill, A
格式:	Journal article
出版:	American Association for the Advancement of Science 2018

相似書籍

Assessment of the Plasmodium falciparum pre-erythrocytic antigen UIS3 as a potential candidate for a malaria vaccine
由: Longley, R, et al.
出版: (2016)

Safety and Immunogenicity of a Novel Recombinant Simian Adenovirus ChAdOx2 as a Vectored Vaccine
由: Folegatti, P, et al.
出版: (2019)

A three-antigen Plasmodium falciparum DNA prime—Adenovirus boost malaria vaccine regimen is superior to a two-antigen regimen and protects against controlled human malaria infection in healthy malaria-naïve adults
由: Sklar, MJ, et al.
出版: (2021)

Pre-clinical development and assessment of viral vectors expressing a fusion antigen of P. falciparum LSA1 and LSAP2 for efficacy against liver-stage malaria
由: Halbroth, B, et al.
出版: (2019)

Identification of immunodominant responses to the Plasmodium falciparum antigens PfUIS3, PfLSA1 and PfLSAP2 in multiple strains of mice
由: Longley, R, et al.
出版: (2015)

Safety and immunogenicity of heterologous prime-boost immunization with viral-vectored malaria vaccines adjuvanted with Matrix-M
由: Venkatraman, N, et al.
出版: (2017)

Safety and immunogenicity of the heterologous prime-boost ebolavirus vaccine regimen CHAD3-EBO Z and MVA-BN (R) FILO in healthy UK adults
由: Rampling, T, et al.
出版: (2015)

Safety and immunogenicity of a heterologous prime-boost Ebola virus vaccine regimen in healthy adults in the United Kingdom and Senegal
由: Venkatraman, N, et al.
出版: (2018)

Activation-induced markers detect vaccine-specific CD4⁺ T cell responses not measured by assays conventionally used in clinical trials
由: Bowyer, G, et al.
出版: (2018)

Safety and Immunogenicity of a Novel Recombinant Simian Adenovirus ChAdOx2 as a Vectored Vaccine
由: Pedro M. Folegatti, et al.
出版: (2019-05-01)

High level efficacy in humans of a next-generation plasmodium falciparum anti-sporozoite vaccine: R21 in Matrix-M (TM) adjuvant
由: Venkatraman, N, et al.
出版: (2017)

Prime-boost vectored malaria vaccines: progress and prospects.
由: Hill, A, et al.
出版: (2010)

Safety and high level efficacy of the combination malaria vaccine regimen of RTS,S/AS01B with ChAd-MVA vectored vaccines expressing ME-TRAP
由: Rampling, T, et al.
出版: (2016)

Safety and immunogenicity of a candidate Middle East respiratory syndrome coronavirus viral-vectored vaccine: a dose-escalation, open-label, non-randomised, uncontrolled, phase 1 trial
由: Folegatti, PM, et al.
出版: (2020)

Comparative assessment of vaccine vectors encoding ten malaria antigens identifies two protective liver-stage candidates.
由: Longley, R, et al.
出版: (2015)

Characterisation of antigenic MHC Class I-restricted T cell epitopes in the glycoprotein of Ebolavirus
由: Powlson, J, et al.
出版: (2019)

An in vitro assay to measure antibody-mediated inhibition of P. berghei sporozoite invasion against P. falciparum antigens
由: Rodriguez-Galan, A, et al.
出版: (2017)

Safety and Immunogenicity of the Heterosubtypic Influenza A Vaccine MVA-NP+M1 Manufactured onthe AGE1.CR.pIX Avian Cell Line
由: Folegatti, P, et al.
出版: (2019)

CXCR3+ T follicular helper cells induced by co-administration of RTS,S/AS01B and viral vectored vaccines are associated with reduced immunogenicity and efficacy against Malaria
由: Ewer (nee Russell), K, et al.
出版: (2018)

A single dose of ChAdOx1 Chik vaccine induces neutralising antibodies against four chikungunya virus lineages in a phase 1 clinical trial
由: Folegatti, P, et al.
出版: (2021)

Identification of Immunodominant Responses to the Plasmodium falciparum Antigens PfUIS3, PfLSA1 and PfLSAP2 in Multiple Strains of Mice.
由: Rhea J Longley, et al.
出版: (2015-01-01)

HETEROLOGOUS PRIME-BOOST VACCINATION WITH ADCH63 AND MVA EXPRESSING MSP1 CAN INDUCE PROTECTIVE EFFICACY AGAINST SPOROZOITE CHALLENGE IN VOLUNTEERS
由: Sheehy, S, et al.
出版: (2010)

Activation-induced Markers Detect Vaccine-Specific CD4+ T Cell Responses Not Measured by Assays Conventionally Used in Clinical Trials
由: Georgina Bowyer, et al.
出版: (2018-07-01)

Safety and immunogenicity of a candidate Middle East respiratory syndrome coronavirus viral-vectored vaccine: a dose-escalation, open-label, non-randomised, uncontrolled, phase 1 trial
由: Folegatti, PM, et al.
出版: (2020)

Assessment of novel vaccination regimens using viral vectored liver stage malaria vaccines encoding ME-TRAP
由: Bliss, C, et al.
出版: (2018)

Expansion of CD57+KLRG1+ T cells is associated with reduced vaccine responses in CMV+ young adults
由: Bowyer, G, et al.
出版: (2020)

Safety and Efficacy of Novel Malaria Vaccine Regimens of RTS,S/AS01B alone, or with Concomitant ChAd63-MVA Vectored Vaccines Expressing ME-TRAP
由: Rampling, T, et al.
出版: (2018)

Development of adjuvanted multi-antigen liver-stage malaria vaccines
由: Halbroth, B
出版: (2016)

Detection of vaccine-induced antibodies to Ebola virus in oral fluid
由: Lambe, T, et al.
出版: (2016)

Safety and immunogenicity of heterologous prime-boost immunisation with Plasmodium falciparum malaria candidate vaccines, ChAd63 ME-TRAP and MVA ME-TRAP, in healthy Gambian and Kenyan adults.
由: Ogwang, C, et al.
出版: (2013)

Phase Ia clinical evaluation of the plasmodium falciparum blood-stage antigen MSP1 in ChAd63 and MVA vaccine vectors
由: Sheehy, S, et al.
出版: (2011)

Phase Ia clinical evaluation of the Plasmodium falciparum blood-stage antigen MSP1 in ChAd63 and MVA vaccine vectors.
由: Sheehy, S, et al.
出版: (2011)

Development of a molecular adjuvant to enhance antigen-specific CD8+ T cell responses
由: Halbroth, B, et al.
出版: (2018)

Safety and immunogenicity of adenovirus and poxvirus vectored vaccines against a Mycobacterium avium complex subspecies
由: Folegatti, P, et al.
出版: (2021)

Comparison of intubating conditions between rocuronium with priming and without priming: Randomized and double-blind study
由: M Hanumantha Rao, et al.
出版: (2011-01-01)

Viral vector malaria vaccines induce high-level T cell and antibody responses in West African children and infants
由: Bliss, C, et al.
出版: (2016)

Mathematical Attack of RSA by Extending the Sum of Squares of Primes to Factorize a Semi-Prime
由: Anthony Overmars, et al.
出版: (2020-09-01)

A Phase Ia study to assess the safety and immunogenicity of new malaria vaccine candidates ChAd63 CS administered alone and with MVA CS
由: De Barra, E, et al.
出版: (2014)

Durability of immune responses induced by three leading candidate ebola vaccine regimes; rVSV ZEBOV, ChAd3 EBO Z-MVA BN-Filo and AdHu26.ZEBOV-MVA BN Filo
由: Ewer, K, et al.
出版: (2018)

Vaccines against Ebola virus
由: Venkatraman, N, et al.
出版: (2017)